Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Eisai Resource Report Resource Website 10+ mentions |
Eisai (RRID:SCR_003936) | Eisai | commercial organization | A global pharmaceutical company. | pharmaceutical, healthcare, drug, oncology, central nervous system, neurology, medicine | is related to: PharmaCog | Cancer, Epilepsy, Alzheimer's disease, Obesity, Immune-mediated disease, Insomnia | grid.418767.b, Wikidata: Q29123933, nlx_158312, ISNI: 0000 0004 0599 8842 | https://ror.org/0469x1750 | SCR_003936 | SciCrunch Registry | Eisai Co. Ltd., EISAI Ltd | 2026-10-17 01:25:42 | 17 | ||||||
|
EORTC Clinical Trials Resource Report Resource Website |
EORTC Clinical Trials (RRID:SCR_004011) | catalog, clinical trial, data or information resource, database | A database that contains information about EORTC (European Organisation for Research and Treatment of Cancer) clinical trials but also clinical trials from other organizations, in which EORTC has been/is participating. The protocol database may be browsed by EORTC Research Group, tumor site, treatment, or drug. | clinical, protocol | has parent organization: EORTC | Cancer | nlx_158511 | SCR_004011 | SciCrunch Registry | European Organisation for Research and Treatment of Cancer Clinical trials, EORTC protocol database | 2026-10-17 01:26:08 | 0 | ||||||||
|
Proteome Sciences Resource Report Resource Website 1+ mentions |
Proteome Sciences (RRID:SCR_004106) | PS | commercial organization | Commercial company delivering content for personalized medicine in the areas of Biomarker Services, Biomarker Assays, Isobaric and Isotopic Reagents and Proprietary Biomarkers. A global leader in applied proteomics, they use high sensitivity proprietary technologies to detect biomarkers (differentially expressed proteins in diseases) and to develop rapid assays for testing. The biomarkers discovered in body fluids or tissues are validated, developed and commercialized as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing. | protein, peptide, biomarker, pharmaceutical, diagnostic, electrophoretics ltd, electrophoretics, proteomics, assay, isobaric, isotopic, reagent, personalized medicine, mass spectrometry, tandem mass tag | is related to: EMIF | Neurodegenerative disorder, Cancer, Stroke, Alzheimer's disease, Traumatic brain injury | nlx_158582 | SCR_004106 | SciCrunch Registry | Proteome Science, Proteome Sciences plc | 2026-10-17 01:25:46 | 3 | |||||||
|
Binding Site Resource Report Resource Website 1+ mentions |
Binding Site (RRID:SCR_004051) | commercial organization | Company provides specialist diagnostic products to clinicians and laboratory professionals worldwide. Specialist protein company committed to research, development, manufacture and distribution of immunodiagnostic assays for global laboratory market. Specialized in antibody specificity technology, Binding Site gives clinicians and laboratory staff tools to significantly improve diagnosis and management of those patients with specific cancers and immune disorders. Binding Site manufactures wide range of products for plasma protein analysis including Freelite, Hevylite and SPAplus. | Diagnostic products, protein, diagnosis, monitoring, assay, immunodiagnostic assays | is related to: Kidney Health Initiative | Cancer, Immune disorder, Multiple Myeloma, Primary immunodeficiency disease | nlx_158482 | SCR_004051 | SciCrunch Registry | The Binding Site, The Binding Site Group Ltd, Binding Site Inc, The Specialist Protein Company, Binding Site Group Ltd | 2026-10-17 01:25:45 | 2 | ||||||||
|
EORTC Resource Report Resource Website 1000+ mentions |
EORTC (RRID:SCR_004070) | EORTC | nonprofit organization | An independent pan-European clinical research organization to improve the standards of cancer care through the multidisciplinary multinational efforts of basic scientists and clinicians. The efforts include the testing of more effective therapeutic strategies based on drugs, surgery and/or radiotherapy that are already in use. They also contribute to the development of new drugs and other approaches in partnership with the pharmaceutical industry which is accomplished mainly by conducting large, multicenter, prospective, randomized, phase III clinical trials. The EORTC Network comprises over 300 hospitals and cancer centers in over 30 countries which include some 2,500 collaborators from all disciplines involved in cancer treatment and research. The EORTC Headquarters staff handle some 6,000 new patients enrolled each year in cancer clinical trials, approximately 30 protocols that are permanently open to patient entry, over 50,000 patients who are in follow-up, and a database of more than 180,000 patients. Intergroup collaboration is also promoted to face current challenges of clinical trials aiming at targeted therapies in order to recruit a large number of patients within a reasonable period of time. | clinical, translational, drug, clinical research organization, drug development, clinical trial |
is related to: GetReal is parent organization of: EORTC Clinical Trials |
Cancer | nlx_158510, grid.434691.d, Wikidata: Q50376884 | https://ror.org/04g9wby70 | SCR_004070 | SciCrunch Registry | European Organisation for Research and Treatment of Cancer, European Organization for Research and Treatment of Cancer | 2026-10-17 01:26:08 | 3133 | ||||||
|
Nutrition and Obesity Research Centers Resource Report Resource Website 10+ mentions |
Nutrition and Obesity Research Centers (RRID:SCR_004131) | NORC | data or information resource, disease-related portal, organization portal, portal, resource, topical portal | Portal to research centers and core facilities specifically support obesity research and better understand the relationship between health and nutrition. | obesity core facility, obesity portal, obesity research center |
is listed by: NIDDK Information Network (dkNET) is listed by: Diabetes Research Centers is affiliated with: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases has organization facet: Boston Nutrition and Obesity Research Centers has organization facet: Nutrition and Obesity Research Centers at Harvard has organization facet: Mid-Atlantic Nutrition Obesity Research Center has organization facet: New York Obesity Nutrition Research Center has organization facet: Pennington Biomedical Research Center Nutrition and Obesity Research Center has organization facet: University of Alabama at Birmingham Nutrition and Obesity Research Center has organization facet: University of California San Francisco Nutrition and Obesity Research Center has organization facet: University of Colorado Anschutz Medical Campus Nutrition and Obesity Research Center has organization facet: University of Michigan Nutrition and Obesity Research Center has organization facet: University of North Carolina at Chapel Hill Nutrition and Obesity Research Center has organization facet: University of Washington Nutrition and Obesity Research Center has organization facet: Washington University St. Louis Nutrition Obesity Research Center |
Obesity, Nutrition-related disease, Eating disorder, Anorexia nervosa, AIDS, Cancer | NIDDK RFA-DK16-006 | Available to the research community | nlx_158684 | SCR_004131 | SciCrunch Registry | 2026-10-17 01:25:47 | 46 | ||||||
|
Duke Cancer Institute Resource Report Resource Website 1+ mentions |
Duke Cancer Institute (RRID:SCR_004338) | DCI | data or information resource, portal, topical portal | One of 40 centers in the country designated by the National Cancer Institute (NCI) as a comprehensive cancer center, it combines cutting-edge research with compassionate care. Its vision is to accelerate research advances related to cancer and improve Duke''s ability to translate these discoveries into the most advanced cancer care to patients by uniting hundreds of cancer physicians, researchers, educators, and staff across the medical center, medical school, and health system under a shared administrative structure. | cancer, patient, research, clinical trial |
is related to: Biospecimen Repository and Processing Core has parent organization: Duke University School of Medicine; North Carolina; USA is parent organization of: DCI Tissue and Blood Procurement Shared Resource |
Cancer | NCI | nlx_143695 | http://www.cancer.duke.edu/ | SCR_004338 | SciCrunch Registry | Duke Cancer Institute: A National Cancer Institute-designated Comprehensive Cancer Center | 2026-10-17 01:26:03 | 1 | |||||
|
Stem Cell Discovery Engine Resource Report Resource Website 50+ mentions |
Stem Cell Discovery Engine (RRID:SCR_004453) | SCDE | analysis service resource, data or information resource, data repository, database, production service resource, service resource, software resource, source code, storage service resource | An online database of curated cancer stem cell (CSC) experiments coupled to the Galaxy analytical framework. Driven by a need to improve our understanding of molecular processes that are common and unique across cancer stem cells (CSCs), the SCDE allows users to consistently describe, share and compare CSC data at the gene and pathway level. The initial focus has been on carefully curating tissue and cancer stem cell-related experiments from blood, intestine and brain to create a high quality resource containing 53 public studies and 1098 assays. The experimental information is captured and stored in the multi-omics Investigation/Study/Assay (ISA-Tab) format and can be queried in the data repository. A linked Galaxy framework provides a comprehensive, flexible environment populated with novel tools for gene list comparisons against molecular signatures in GeneSigDB and MSigDB, curated experiments in the SCDE and pathways in WikiPathways. Investigation/Study/Assay (ISA) infrastructure is the first general-purpose format and freely available desktop software suite targeted to experimentalists, curators and developers and that: * assists in the reporting and local management of experimental metadata (i.e. sample characteristics, technology and measurement types, sample-to-data relationships) from studies employing one or a combination of technologies; * empowers users to uptake community-defined minimum information checklists and ontologies, where required; * formats studies for submission to a growing number of international public repositories endorsing the tools, currently ENA (genomics), PRIDE (proteomics) and ArrayExpress (transcriptomics). Galaxy allows you to do analyses you cannot do anywhere else without the need to install or download anything. You can analyze multiple alignments, compare genomic annotations, profile metagenomic samples and much much more. Best of all, Galaxy''''s history system provides a complete analyses record that can be shared. Every history is an analysis workflow, which can be used to reproduce the entire experiment. The code for this Galaxy instance is available for download from BitBucket. | stem cell, analysis, cancer stem cell, galaxy, gene, pathway, molecular signature, tissue, bio.tools, FASEB list |
is listed by: Debian is listed by: bio.tools is related to: Galaxy is related to: Galaxy is related to: ISA Infrastructure for Managing Experimental Metadata has parent organization: Harvard T.H. Chan School of Public Health |
Cancer | NCI 1RC2CA148222-01 | PMID:22121217 | Free, The community can contribute to this resource | biotools:scde_discovery, nlx_44656 | https://bio.tools/scde_discovery | SCR_004453 | SciCrunch Registry | Harvard Stem Cell Discovery Engine, SCDE - Stem Cell Discovery Engine | 2026-10-17 01:26:12 | 57 | |||
|
Foundation for the National Institutes of Health Resource Report Resource Website 1000+ mentions |
Foundation for the National Institutes of Health (RRID:SCR_004493) | FNIH | institution | A public charity whose mission is to support the NIH in its mission to improve health, by forming and facilitating public-private partnerships for biomedical research and training. Its vision is Building Partnerships for Discovery and Innovation to Improve Health. The FNIH draws together the world''s foremost researchers and resources, pressing the frontier to advance critical discoveries. They are recognized as the number-one medical research charity in the countryleveraging support, and convening high level partnerships, for the greatest impact on the most urgent medical challenges we face today. Grants are awarded as part of a public-private partnership with the National Heart, Lung, and Blood Institute (NHLBI) on behalf of The Heart Truth in support of women''s heart health education and research. Funding for the Community Action Program is provided by the FNIH through donations from individuals and corporations including The Heart Truth partners Belk Department Stores, Diet Coke, and Swarovski. Successful biomedical research relies upon the knowledge, training and dedication of those who conduct it. Bringing multiple disciplines to bear on health challenges requires innovation and collaboration on the part of scientists. Foundation for NIH partnerships operate in a variety of ways and formats to recruit, train, empower and retain their next generation of researchers. From lectures and multi-week courses, to scholarships and awards through fellowships and residential training programs, their programs respond to the needs of scientists at every level and stage in their careers. | biomedical research |
is related to: Osteoarthritis Biomarkers Project (OABP) is parent organization of: Biomarkers Consortium is parent organization of: Observational Medical Outcomes Partnership is parent organization of: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is parent organization of: Accelerating Medicines Partnership - Alzheimers is parent organization of: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is parent organization of: Genetic Association Information Network (GAIN) |
Type 1 diabetes, Type 2 diabetes, Diabetes, Metabolic disease, Alzheimer's disease, Schizophrenia, Prostate cancer, Demantia, Muscular dystrophy, Tuberculosis, HIV, Parkinson's disease, Osteoarthritis, Age-related eye disease, Visceral leishmaniasis, Undiagnosed disease, Cancer, Non-small cell lung cancer, Malaria, Systemic lupus erythematosus, COVID-19, Acute lymphoblastic leukemia | ISNI: 0000 0000 9836 9834, Wikidata: Q16837497, nlx_143768, Crossref funder ID: 100000009, grid.428807.1 | https://ror.org/00k86s890 | SCR_004493 | SciCrunch Registry | Foundation for NIH | 2026-10-17 01:26:12 | 2193 | ||||||
|
Capital Biosciences Resource Report Resource Website 1+ mentions |
Capital Biosciences (RRID:SCR_004879) | commercial organization | Biological products including Cell Immortalization Products, Clinically Defined Human Tissue, cDNA ORF Clones, Premade Adenoviruses, Purified Proteins, Viral Expression Systems and others as well as services like Custom Recombinant Adenovirus Production, Custom Recombinant Lentivirus Production, Protein Detection and Quantification and Stable Cell Line Production for academic and governmental research institutes, pharmaceutical and biotechnology industry. Capital Biosciences offers most types of human tissues, normal and diseased, with extensive clinical history and follow up information. Standard specimen format: Snap-frozen(flash-frozen), Formalin fixed and paraffin embedded (FFPE) tissues, Blood and blood products, Bone marrow, Total RNA, Genomic DNA, Total Proteins, Primary cell cultures, Viable frozen tissue. Tumor tissue samples include: Bladder cancer, Glioblastoma, Medulloblastoma, Breast Carcinoma, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Head and Neck (H&N) Carcinoma, Hepatocellular Carcinoma (HCC), Hodgkin's lymphoma, Kidney, Renal Cell Carcinoma, Lung Cancer, Non-Small Cell (NCSLC), Lung Cancer, Small Cell (SCLC), Melanoma, Mesothelioma, non-Hodgkin's Lymphoma, Ovarian Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Stomach Cancer. | cell immortalization, clinical, tissue, cdna orf clone, premade adenovirus, purified protein, viral expression, recombinant adenovirus, recombinant lentivirus, protein, detection, quantification, cell line, disease, formalin fixed and paraffin embedded, frozen, tissue, blood, blood product, bone marrow, rna, dna, protein, cell culture, tumor tissue | is listed by: One Mind Biospecimen Bank Listing | Normal, Cancer, Tumor, Bladder cancer, Glioblastoma, Medulloblastoma, Breast Carcinoma, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Head Carcinoma, Neck Carcinoma, Hepatocellular Carcinoma, Hodgkin's lymphoma, Kidney, Renal Cell Carcinoma, Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell, Melanoma, Mesothelioma, Non-Hodgkin's Lymphoma, Ovarian Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Stomach Cancer | nlx_85333 | http://www.capitalbiosciences.com/category/show/tissue-human-clinically-defined.html | SCR_004879 | SciCrunch Registry | Capital Biosciences: innovative solutions for life sciences, Capital Biosciences Inc. | 2026-10-17 01:26:05 | 2 | |||||||
|
Southeastern Brain Tumor Foundation Resource Report Resource Website |
Southeastern Brain Tumor Foundation (RRID:SCR_004768) | SBTF | institution | Founded in 1995, the Southeastern Brain Tumor Foundation (SBTF), a 501c3 not-for-profit charitable foundation, is devoted to improve the quality of life for brain tumor patients and their families. By offering information, education and support services, we aspire to instill hope, knowledge and comfort to all involved. The Southeastern Brain Tumor Foundation also raises funds for research and medical personnel so that a cure can be found. For over a decade, the SBTF has become a well-known fundraising entity supporting critical, cutting edge brain tumor research at major medical centers in the Southeast. Our annual Race for Research held in Atlanta, Georgia each summer, is our main fundraising event popular throughout Atlanta and the surrounding metropolitan area and has funded over $1.2 million dollars in research grants to leading researchers at major medical centers throughout the Southeast over the past decade. We are proud of our dedicated, all volunteer Board of Directors who meet monthly. Our Board is a diverse group comprised of individuals who''ve been touched by brain tumors in many different ways. Ranging from patients and family members to healthcare professionals; we are all committed to promoting the awareness of brain tumors in the community, communicating with patients and families and raising critical funds for research grants furthering advancements in the treatment of brain tumors. Our monthly support group, lead by a nurse practitioner, welcomes patients and their families to sit side by side with each other, share their experiences, communicate and receive support. As a neurosurgeon-scientist focused on the treatment of patients with brain tumors, I am committed to advancing the mission of SBTF forward in the fight against brain tumors. Our ability to serve the brain tumor community is dependent on each of you. Whether you support us with a financial donation in our fundraising efforts or with your time as a volunteer, each of you are a vital and integral part of our success and we thank you. | brain, tumor | Cancer, Brain cancer, Brain tumor | Crossref funder ID: 100003421, ISNI: 0000 0004 5902 7216, grid.481206.9, nlx_143897 | https://ror.org/01v0qv381 | SCR_004768 | SciCrunch Registry | 2026-10-17 01:26:08 | 0 | ||||||||
|
VirusSeq Resource Report Resource Website 10+ mentions |
VirusSeq (RRID:SCR_005206) | VirusSeq | software resource | An algorithmic software tool for detecting known viruses and their integration sites using next-generation sequencing of human cancer tissue. VirusSeq takes FASTQ files (paired-end reads) as input. | next-generation sequencing, virus, integration site, cancer tissue, genome, rna-seq, whole genome sequencing, fastq, paired-end read, bio.tools |
is listed by: OMICtools is listed by: bio.tools is listed by: Debian has parent organization: University of Texas MD Anderson Cancer Center |
Cancer | OMICS_00227, biotools:virusseq | https://bio.tools/virusseq | SCR_005206 | SciCrunch Registry | 2026-10-17 01:26:12 | 23 | |||||||
|
SnpEff Resource Report Resource Website 5000+ mentions |
SnpEff (RRID:SCR_005191) | SnpEff | software resource | Genetic variant annotation and effect prediction software toolbox that annotates and predicts effects of variants on genes (such as amino acid changes). By using standards, such as VCF, SnpEff makes it easy to integrate with other programs. | genome, genetic variant, annotation, effect, variant, gene, cancer variant, gatk, hgsv, single nucleotide polymorphisms, genome sequence, java, bio.tools |
is listed by: OMICtools is listed by: Debian is listed by: bio.tools is related to: Galaxy is related to: GATK has parent organization: SourceForge has parent organization: Wayne State University; Michigan; USA works with: SnpSift |
Cancer | PMID:22728672 | Free, Freely available | biotools:snpeff, OMICS_00186 | https://bio.tools/snpeff, https://sources.debian.org/src/snpeff/ | SCR_005191 | SciCrunch Registry | SnpEff - Genetic variant annotation and effect prediction toolbox | 2026-10-17 01:26:14 | 5640 | ||||
|
SomaticSniper Resource Report Resource Website 100+ mentions |
SomaticSniper (RRID:SCR_005108) | SomaticSniper | software resource | Software program to identify single nucleotide positions that are different between tumor and normal (or, in theory, any two bam files). It takes a tumor bam and a normal bam and compares the two to determine the differences. It outputs a file in a format very similar to Samtools consensus format. It uses the genotype likelihood model of MAQ (as implemented in Samtools) and then calculates the probability that the tumor and normal genotypes are different. This probability is reported as a somatic score. The somatic score is the Phred-scaled probability (between 0 to 255) that the Tumor and Normal genotypes are not different where 0 means there is no probability that the genotypes are different and 255 means there is a probability of 1 ? 10(255/-10) that the genotypes are different between tumor and normal. This is consistent with how the SAM format reports such probabilities. It is currently available as source code via github or as a Debian APT package. |
is listed by: OMICtools has parent organization: Washington University in St. Louis; Missouri; USA |
Cancer, Tumor, Normal | PMID:22155872 | Acknowledgement requested | OMICS_00092 | SCR_005108 | SciCrunch Registry | 2026-10-17 01:26:05 | 152 | |||||||
|
SomaticIndelDetector Resource Report Resource Website 50+ mentions |
SomaticIndelDetector (RRID:SCR_005107) | SomaticIndelDetector | software resource | Tool for calling indels in Tumor-Normal paired sample mode. | cancer-specific variant discovery tool, variant, tumor, normal, bam, indel |
is listed by: OMICtools has parent organization: Broad Institute |
Cancer, Tumor, Normal | OMICS_00091 | SCR_005107 | SciCrunch Registry | 2026-10-17 01:26:10 | 82 | ||||||||
|
Mario Negri Institute for Pharmacological Research; Milan; Italy Resource Report Resource Website |
Mario Negri Institute for Pharmacological Research; Milan; Italy (RRID:SCR_011361) | Mario Negri Institute | institution | A not-for-profit biomedical research institute whose main aim is to help defend human health and life. Research programs span from the molecular level to the whole human being, and the findings help build up the basis for developing new drugs, and making existing ones more effective. The main research headings are the battle against cancer, nervous and mental illnesses, cardiovascular and kidney diseases, rare diseases and the toxic effects of environmental contaminants, mother and child''''s health. The Institute is also involved in research on pain relief and drug addiction. Parallel to its biomedical investigations, the Mario Negri Institute runs training schemes for laboratory technicians and graduate researchers. It takes part in a range of initiatives to communicate information in biomedicine, on a general level and with the specific aims of improving health care practice, and encouraging more rational use of drugs. There are also research units in Bergamo, at Ranica - near Bergamo - and at Santa Maria Imbaro, near Chieti. | is related to: PharmaCog | Cancer, Nervous illness, Mental illnesses, Cardiovascular disease, Kidney disease, Rare disease, Environmental contaminant toxicity | nlx_158317 | SCR_011361 | SciCrunch Registry | Mario Negri Institute for Pharmacological Research, Istituto di Ricerche Farmacologiche Mario Negri, Mario Negri Istituto di Ricerche Farmacologiche | 2026-10-17 01:27:36 | 0 | ||||||||
|
Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka; Japan Resource Report Resource Website |
Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka; Japan (RRID:SCR_011477) | OMCCCD | institution | Center for cancer and cardiovascular diseases with a focus on advanced cancer therapy in the Kansai area. It consists of the Hospital, the Research Institute, and the Department of Cancer Control and Statistics. The Research Institute is responsible for acquiring and applying knowledge of the molecular and genetic aspects of human cancer. The mission of the Research Institute is to perform basic and applied cancer research through collaboration with the Hospital and the Department of Cancer Control and Statistics. The large tumor tissue collection is the major focus of their research efforts. The Research Institute includes seven official departments: Biology, Biochemistry, Pathology, Molecular Medicine & Pathophysiology, Molecular Biology, Molecular Genetics, and Immunology. In addition, a group conducted by the Director (Director''s Unit) and Laboratory of Genome Informatics. The research objectives are as follows. # Clinical research. ## Prognosis predictor of gliomas based on gene expression profiling ## Targeted oncolytic virus # Technical developments for cancer research ## A new method for storing cancer cells taken from human tumor tissues (cancer tissue-originated spheroid) ## Bioinformatics for personalized genomics # Basic research ## Mechanism of metastasis ## Low oxygen environment and cancer ## Structure analysis of oligosaccharide on human cancer cells ## Proof-of-principle study of artificial adjuvants | is parent organization of: Brain Gene Expression Database | Cancer, Cardiovascular disease | nlx_66393 | SCR_011477 | SciCrunch Registry | 2026-10-17 01:28:31 | 0 | |||||||||
|
CaTCh FISH Chip Resource Report Resource Website 1+ mentions Rating or validation data |
CaTCh FISH Chip (RRID:SCR_015810) | resource | Equipment that is a magnetic micropore chip for rapid unbiased circulating tumor cell isolation and in situ RNA analysis. The chip detects tumor cells and can help doctors treat patients with these tumors. | hardware, instrument, equipment, magnetic micropore, micropore chip, tumor cell isolation, rna analysis, in situ, microtechnology, microchip, bioengineering | Pancreatic cancer, cancer | PMID:28809985 | Commercially available | SCR_015810 | SciCrunch Registry | 2026-10-17 01:29:04 | 1 | |||||||||
|
Genome Alteration Print Resource Report Resource Website 1+ mentions |
Genome Alteration Print (RRID:SCR_012016) | GAP | software resource | Software for automatic detection of absolute segmental copy numbers and genotype status in complex cancer genome profiles measured by single-nucleotide polymorphism (SNP) arrays. The method is based on pattern recognition of segmented and smoothed copy number and allelic imbalance profiles. The method performs well even for poor-quality data, low tumor content, and highly rearranged tumor genomes. | genome, segmental copy number, genotype, genome profile, copy number, single-nucleotide polymorphism, array |
is listed by: OMICtools has parent organization: Curie Institute; Paris; France |
Cancer, Tumor | PMID:19903341 | OMICS_02119 | SCR_012016 | SciCrunch Registry | Genome Alteration Print (GAP): Mining complex cancer genomic profiles | 2026-10-17 01:28:27 | 4 | ||||||
|
German Cancer Research Center Resource Report Resource Website 1+ mentions |
German Cancer Research Center (RRID:SCR_012942) | DKFZ | institution | Biomedical research institute in Germany that investigates the mechanisms of cancer and works to identify cancer risk factors. They provide the foundations for developing novel approaches in the prevention, diagnosis, and treatment of cancer and are a member of the Helmholtz Association of National Research Centers. Professor Harald zur Hausen was awarded the Nobel Prize for Medicine for his outstanding scientific contribution to the study of human papillomaviruses (HPV). In addition, the staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. The Center is funded by the German Federal Ministry of Education and Research (90%) and the State of Baden-Württemberg (10%). |
is related to: Helmholtz Center Munich is related to: MIP-DILI is parent organization of: AutoPrime is parent organization of: Axel Database is parent organization of: glycomedb is parent organization of: MITK Diffusion is parent organization of: LifeDB is parent organization of: LipOXygenases DataBase is parent organization of: Diffusion MRI - In-vivo and Phantom Data is parent organization of: Diffusion MRI at DKFZ Heidelberg is parent organization of: DKFZ Genomics and Proteomics Core Facility is parent organization of: German Cancer Research Center Labs and Facilities is parent organization of: GenomeRNAi is parent organization of: Division of Molecular Genome Analysis is parent organization of: LiGraph is parent organization of: pdb-data is parent organization of: GENSCAN is parent organization of: DKFZ Small Animal Imaging Core Facility |
Cancer | grid.7497.d, Wikidata: Q449325, ISNI: 0000 0004 0492 0584, nlx_36666, Crossref funder ID: 100008658 | https://ror.org/04cdgtt98 | SCR_012942 | SciCrunch Registry | Deutsches Krebsforschungszentrum | 2026-10-17 01:28:35 | 7 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
